Home/Filings/4/0001209191-23-032910
4//SEC Filing

McClung David Mark 4

Accession 0001209191-23-032910

CIK 0001001233other

Filed

May 29, 8:00 PM ET

Accepted

May 30, 4:43 PM ET

Size

6.4 KB

Accession

0001209191-23-032910

Insider Transaction Report

Form 4
Period: 2023-05-25
McClung David Mark
EVP Chief Business Officer
Transactions
  • Tax Payment

    Common Stock

    2023-05-25$1.33/sh1,925$2,560222,849 total
Footnotes (2)
  • [F1]Represents shares underlying the portion of a restricted stock unit ("RSU") grant that vested on May 25, 2023, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on May 25, 2023 of $1.33/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise.
  • [F2]Includes: (a) 3,643 shares resulting from the May 25, 2023 vesting installment of the Reporting Person's February 25, 2022 RSU grant, and the remaining 38,982 shares will vest in successive equal quarterly installments through February 25, 2025, (b) 33,340 shares subject to the Reporting Person's June 25, 2020 RSU grant that will vest in one final installment on June 25, 2023, (c) 13,336 shares subject to Reporting Person's February 25, 2021 RSU grant that will vest in one final installment on February 25, 2024 and (d) 56,250 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.

Issuer

SANGAMO THERAPEUTICS, INC

CIK 0001001233

Entity typeother

Related Parties

1
  • filerCIK 0001811505

Filing Metadata

Form type
4
Filed
May 29, 8:00 PM ET
Accepted
May 30, 4:43 PM ET
Size
6.4 KB